Filing Details
- Accession Number:
- 0001209191-20-039144
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-26 17:46:13
- Reporting Period:
- 2020-06-25
- Accepted Time:
- 2020-06-26 17:46:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1673772 | Rapt Therapeutics Inc. | RAPT | Pharmaceutical Preparations (2834) | 473313701 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1783296 | C Karen Lam | C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080 | Vp, Finance & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-06-25 | 875 | $35.00 | 12,735 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2020.
Billionaire Hedge Funds
